MORPHOSYS
Live / Registered — Registered (as of 06 Jun 2023)
What this means for you
Registered since 06 Jun 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97042228
- Registration number
- 7071326
- Mark type
- Stylized text
- Filed
- 23 Sept 2021
- Published for opposition
- 21 Mar 2023
- Registered
- 06 Jun 2023
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 001 — Chemicals: reagents for scientific and medical research for use in the research and production of small molecule pharmaceuticals; active pharmaceutical ingredients, namely, antibodies, proteins and small molecules for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of diseases that involve dysregulation of epigenetic pathways; pharmaceutical preparations for epigenetic modulators as therapeutics; pharmaceuticals comprising small molecules for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; small molecule compounds for use as drug delivery agents in pharmaceuticals; small molecule compounds being pharmaceuticals for the treatment and prevention of diseases and disorders, namely, metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis in humans; small molecule pharmaceuticals for the treatment of diseases and conditions, namely, metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; Pharmaceuticals and pharmaceutical preparations for human use for the treatment and prevention of diseases and disorders, namely, metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; diagnostic preparations for medical purposes; biological substances for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; Clinical medical reagents; Biological preparations for medical purposes, namely, for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; pharmaceutical and veterinary preparations, agents and substances for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis
- Class 042 — Scientific and technological services: Pharmaceutical research and development of pharmaceutical preparations, medicines and vaccines; providing medical and scientific research information; Scientific research in the nature of conducting clinical trials for others; scientific and technological services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; research and design services, namely, research and development in the field of antibodies and clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis
Owner
- MorphoSys AG, Planegg, DE
- MorphoSys AG, Planegg, DE
- MorphoSys AG, Planegg, DE
Prior registrations
Prosecution history
- 21 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Mar 2025 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 21 Mar 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Mar 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Mar 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 21 Mar 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 06 Jun 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Jun 2023 — REGISTERED-PRINCIPAL REGISTER
- 21 Mar 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Mar 2023 — PUBLISHED FOR OPPOSITION
- 01 Mar 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Feb 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Feb 2023 — EXAMINER'S AMENDMENT ENTERED
- 10 Feb 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 10 Feb 2023 — EXAMINERS AMENDMENT E-MAILED